Inflammatory cytokines and microbe-borne immunostimulators have emerged as triggers of depressive behavior. Behavioral alterations affect patients chronically infected by the parasite Trypanosoma cruzi. We have previously shown that C3H/He mice present acute phase-restricted meningoencephalitis with persistent central nervous system (CNS) parasitism, whereas C57BL/6 mice are resistant to T. cruzi-induced CNS inflammation. In the present study, we investigated whether depression is a long-term consequence of acute CNS inflammation and a contribution of the parasite strain that infects the host. C3H/He and C57BL/6 mice were infected with the Colombian (type I) and Y (type II) T. cruzi strains. Forced-swim and tail-suspension tests were used to assess depressive-like behavior. Independent of the mouse lineage, the Colombian-infected mice showed significant increases in immobility times during the acute and chronic phases of infection. Therefore, T. cruzi-induced depression is independent of active or prior CNS inflammation. Furthermore, chronic depressive-like behavior was triggered only by the type I Colombian T. cruzi strain. Acute and chronic T. cruzi infection increased indoleamine 2,3-dioxygenase (IDO) expression in the CNS. Treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine abrogated the T. cruzi-induced depressive-like behavior. Moreover, treatment with the parasiticide drug benznidazole abrogated depression. Chronic T. cruzi infection of C57BL/6 mice increased tumor necrosis factor (TNF) expression systemically but not in the CNS. Importantly, TNF modulators (anti-TNF and pentoxifylline) reduced immobility. Therefore, direct or indirect parasite-induced immune dysregulation may contribute to chronic depressive disorder in T. cruzi infection, which opens a new therapeutic pathway to be explored.
Introduction
Stressors such as inflammatory cytokines have emerged as triggers of depressive behavior Maes et al., 2009 ). Microbe-borne molecules such as lipopolysaccharide (LPS) (Gibb et al., 2011) and the human immunodeficiency virus type 1 (HIV-1) Tat protein (Fu et al., 2011) induce cytokine-associated depressive-like behavior in mice. Furthermore, sustained increases in the production of the pro-inflammatory cytokines interferon-gamma (IFNc) and tumor necrosis factor (TNF) and an enhanced activation of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) induced by Bacillus Calmette-Guerin (BCG) have been shown to be associated with depressive-like behavior (Moreau et al., 2008) . More recently, studies assessing the acute central administration of TNF have reinforced the importance of proinflammatory cytokines in the pathophysiology of depression (Kaster et al., 2012) . In Chagas disease, a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi , evidence of central nervous system (CNS) abnormalities in chronic patients includes alterations in quantitative electroencephalograms, sleep dysfunction, memory impairment and depression (Prost et al., 2000; Silva et al., 2010) , although the causes of these manifestations remain elusive. In the acute phase of infection, T. cruzi colonizes the CNS of humans and experimental models (Pittella, 2009; Silva et al., 2010) . The transition from acute to chronic infection is accompanied by a decline in systemic parasite load and CNS parasitism in response to an effective immune response (Roffê et al., 2003; Junqueira et al., 2010; Silva et al., 2010) . In contrast to the cardiomyopathy associated with myocarditis (Freitas et al., 2005) , inflammation in the CNS is rare in the chronic phase, even though the parasite persists in the nervous tissue in an apparently silent manner (Silva et al., 2010) . The existence of a chronic nervous form of Chagas disease remains a matter of debate (Silva et al., 2010) . Although neurologic involvement has been considered to be independent of heart lesions (Prost et al., 2000) , neurocognitive dysfunctions and mood disorders such as depression have been proposed as secondary consequences of inflammatory heart disease (Mosovich et al., 2008) . The severity of Chagas' heart disease is associated with an immune dysbalance that favors IFNc and TNF over interleukin (IL)-10 in the cardiac tissue and periphery (Dutra et al., 2009 ). However, the participation of cytokines in mood disorders associated with Chagas disease has not been explored.
In an attempt to understand the complexity of the involvement of the CNS in T. cruzi infection, we have previously shown that C3H/He (H-2 k ) mice infected with the Colombian strain develop severe meningoencephalitis with enrichment in macrophages and CD8 + T-cells that is restricted to the acute infection, whereas C57BL/6 (H-2 b ) mice are resistant to T. cruzi-induced meningoencephalitis (Silva et al., 1999; Roffê et al., 2003) . In both mouse lineages, acute myocarditis progresses to chronic cardiomyopathy that occurs in a pro-inflammatory milieu (Medeiros et al., 2009; Silverio et al., 2012) .
The present work was conducted to test the hypothesis that, in Chagas disease, chronic mood disorders are long-term consequences of acute T. cruzi-induced CNS inflammation. Toward this end, we used murine models and focused on tests that explore psychomotor skills and depressive-like behavior. Once a depressive phenotype was observed in T. cruzi-infected mice, we determined the abilities of the antidepressant fluoxetine and the parasiticide drug benznidazole to ameliorate depression in this model. Furthermore, because the genetic diversity of T. cruzi strains may contribute to the pathogenesis of Chagas disease (Zingales et al., 2012) , we tested whether the infecting T. cruzi strain affects behavioral changes. Lastly, because an immunological dysbalance with high TNF plasma levels is a feature of chronic Chagas disease (Dutra et al., 2009; Lannes-Vieira et al., 2011) , we also investigated the existence of an inflammatory component in T. cruzi-induced depressive-like behavior by targeting TNF.
Methods

Animals
Four-to six-week-old female mice of the C3H/He (H-2 k ) or C57BL/6 (H-2 b ) lineages with an average weight of between 15-22 g were obtained from the animal facilities of the Oswaldo Cruz Foundation (CECAL, Rio de Janeiro, Brazil). The infected and uninfected experimental groups of animals consisted of 3-10 mice per group. All experimental procedures were repeated twice or 3 times. The experimental groups consisted of the following: 6 animals of each lineage per experiment to follow parasitemia (Fig. 1A) ; 10 animals of each lineage per experiment to follow survival (Fig. 1B) ; 5 animals of each lineage per experimental point to follow CNS inflammation and parasitism ( Fig. 1A and B, Table S1 ); 10 non-infected (NI), 8 acutely and 6 chronically T. cruzi-infected C57BL/6 mice for examination in the open-field test (Fig. S1) ; 8 NI and 9 T. cruzi-infected mice of each lineage per experimental point for examination in the open-field test (Fig. 2) ; 10 NI, 7 acutely and 7 chronically T. cruzi-infected C3H/He mice for examination in the open-field test (Fig. S2) ; 3 NI and 5 T. cruzi-infected C57BL/6 mice and 4 NI and 6 T. cruzi-infected C3H/He mice per experiment to evaluate body weight in a kinetic study (Fig. S3A and S3B) ; 7 NI and 8 T. cruzi-infected C57BL/6 or C3H/He mice per experimental point to evaluate body weight and temperature ( Fig. S3C-S3H) ; 8 NI and 9 T. cruzi-infected C3H/He mice per experimental point and 5 NI and 10 T. cruzi-infected C57BL/6 mice per experimental point subjected to the tail-suspension test (TST) and, sequentially, to the forced-swim test (FST) (Fig. 3) ; 6 T. cruzi-infected C3H/He mice to follow parasitemia (Fig. 4A) ; 3 NI and 5 T. cruzi-infected C3H/He mice per experimental point to perform TST and immunohistochemical studies (Fig. 4B-D) ; 9 NI and 30 T. cruzi-infected C3H/He mice for the kinetic study (Fig. 5A) ; 4-5 NI and 7-10 T. cruzi-infected C3H/He or C57BL/6 mice per experimental group to be checked for body weight and rectal temperature, submitted to the indicated treatment and subjected to the TST and, sequentially, to the FST and studies for detection of mRNA ( Fig. 5B-F) ; 10 NI and 5-16 acutely T. cruzi-infected C3H/He mice per experimental group submitted to the indicated treatment and subjected to the TST ( Fig. 6A and B, Table 1 ) and studies for detection of mRNA (Fig. 7C) ; 5 NI and 3-10 chronically T. cruzi-infected C3H/He mice per experimental group submitted to the indicated treatment and subjected to the TST (Fig. 6C) ; 3-4 NI and 4-10 T. cruzi-infected C57BL/6 mice per experimental group submitted to the indicated treatment and subjected to the TST and studies for detection of mRNA (Fig. 7) . The animals were housed in polypropylene cages that measured 30 Â 20 Â 13 cm and covered by a stainless steel lid. The mice were housed in groups of 5. The bedding material consisted of sterile wood chips. The animals were maintained under standard conditions (with temperature and relative humidity of approximately 22 ± 2°C and 55 ± 10%, respectively) and received food and water ad libitum. This study was conducted in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Brazilian National Council of Animal Experimentation (http://www.cobea.org.br/) and Federal Law 11.794 (October 8, 2008) . The Institutional Committee for Animal Ethics of Fiocruz approved all procedures (CEUA/Fiocruz, License 004/09).
Parasites and experimental T. cruzi infection
Mice were infected intraperitoneally with 100 blood trypomastigote (bt) forms of the type I Colombian strain of T. cruzi (Zingales et al., 2012) , which is considered myotropic (Melo and Brener, 1978) and has previously been shown to colonize the CNS (Silva et al., 1999; Roffê et al., 2003) . The parasite was maintained by serial passage in mice every 35 days post-infection (dpi). Parasitemia was quantitated weekly during the acute and chronic infection phases using Brener's method from 5 lL of tail vein blood; the presence of the rare trypomastigotes marked the onset of the chronic phase as previously described (Silva et al., 1999; dos Santos et al., 2001) . In some experiments, the animals were infected with 500-bt of the type II Y strain (Zingales et al., 2012) , which is considered macrophagotropic (Melo and Brener, 1978) . This strain was maintained by serial passage in mice every 8 dpi.
Behavioral tests
All behavioral experiments occurred during the light phase between 8:00 am and 6:00 pm and were recorded with a DSC-DVD810 video camera (Sony, USA). To minimize stress and maximize familiarity, all behavioral tests applied to the different experimental groups were conducted in an environment with a 12-h Fig. 1 . C3H/He mice are susceptible to acute Trypanosoma cruzi-induced CNS inflammation and C57BL/6 mice are resistant. C3H/He and C57BL/6 mice were infected with 100-bt forms of the type I Colombian T. cruzi strain. (A) Mice of the C3H/He lineage presented more parasitemia during the acute phase (7-49 dpi) compared with C57BL/6 mice. In the chronic phase (90-120 dpi), few to no parasites were detected in the peripheral blood of mice of either lineage. The means ± SD of parasites/mL of peripheral blood are shown. (B) A survival curve revealing that approximately 80% of the T. cruzi-infected C3H/He and C57BL/6 mice survived the acute phase and developed chronic infection. (C) Photomicrographs of the hippocampus of T. cruzi-infected C3H/He mice at the acute phase (30 dpi) showing the presence of T. cruzi amastigote forms inside glial cells. The upper-left panel shows amastigote forms (green color) revealed by staining with the anti-parasite antibody followed by FITC-conjugated secondary antibody. The lower-left panel shows a glial cell stained with anti-GFAP (astrocyte; red color) revealed with TRITC-conjugated secondary antibody. The upper-right panel shows the colocalization (yellow) of T. cruzi amastigote forms (red), revealed by the anti-parasite antibody followed by TRITC-conjugated secondary antibody, inside F4/80 + cells (microglial cells, green) stained with anti-F4/80 antibody followed by FITC-conjugated secondary antibody. The lower-right panel shows the co-localization (yellow) of T. cruzi amastigote forms (green), revealed by the anti-parasite antibody followed by FITC-conjugated secondary antibody, inside GFAP + cells (astrocytes, red) stained with anti-GFAP followed by TRITC-conjugated secondary antibody. Left panels, Bar = 50 lm. light and 12-h dark cycle, a room temperature of 22 ± 2°C and an ambient noise level of approximately 40 dB produced by an air conditioner. To analyze depressive and locomotor/exploratory activity, the animals were subjected to the behavioral tests starting at 7 dpi or from 30 to 42 dpi (acute phase) and at 90 or 120 dpi (chronic phase) when the animals were infected with the Colombian strain and at 7, 14 and 21 dpi (acute phase) and 28 and 35 dpi (chronic phase) for the Y strain. In experiments with intervention during the chronic infection with the Colombian strain, treatment started at 120 dpi and the animals were subjected to behavioral tests at 150 dpi. When animals were re-used, the tests were performed on consecutive days according to the following sequence: day 1, open-field test; day 2, TST; day 3, FST.
No animal was re-tested. To further assess sickness alterations that might have contributed to behavioral alterations (Rogers et al., 2001) , we checked rectal temperature with a rectal probe (Thermometer DT-610B, ATP, USA), apathy and body weight loss.
The open-field test
Emotionality, locomotor and exploratory activity were tested using a modified version of the open-field arena; because the animals have never been in the test environment, they tend to explore it (Hall, 1941) . The open field was a white wooden arena measuring 60 Â 60 cm (3600 cm 2 ). The floor of the apparatus was divided by black grid lines into 49 squares of approximately 8.5 cm each and two imaginary areas -the periphery (40 squares along the walls) and center (9 squares in the central area of the apparatus). Each mouse was placed at the same location in a corner square of the peripheral area. After initial tests using different times of observation (five-, ten-and thirty-minute test sessions), the assay was established and the animals were tested in five-minute sessions. Activities were recorded using a video camera (Sony, USA). To assess the number of behavioral elements, the following parameters were utilized: (i) outer locomotor activity, i.e., when the animals crossed each grid line with all four paws in the peripheral area; (ii) inner locomotor activity, i.e., when the animals crossed each grid line with all four paws in the central area; and (iii) rearing activity, i.e., when the animals rose on their hind legs. The apparatus was cleaned with 70% alcohol and dried with gauze between tests.
The tail-suspension test (TST)
Animals subjected to the short-term, inescapable stress of being suspended by their tail will develop an immobile posture. Immobility is defined as the absence of initiated movements and includes passive swaying. In this test, adapted from Steru and coworkers (1985) , the mouse was hung upside-down using adhesive tape to fix its tail to a vertical surface (an iron rod with a height of 30 cm). A square platform made of white wood was positioned horizontally 20 cm below the iron rod, just under the mouse's forepaws, in such a way that the mouse could lightly touch the platform and minimize the weight sustained by its tail until the recording began. The animal's behavior was recorded with a video camera for 5 min (Sony, USA). The total time of immobility was measured. The animal was considered immobile when it was not struggling, attempting to catch the adhesive tape or showing body torsion or jerky movements.
The forced-swim test (FST)
The FST procedure consisted of placing the mouse inside a cylindrical glass tank (height 35 cm, diameter 25 cm) containing clean water at 24-26°C to a level of 20 cm above the bottom (adapted from Porsolt, 2000) . The animals were left in the cylinder for 6 min. After the first 2 min, the total duration of immobility was measured over a period of 4minutes. The mouse was considered to be immobile when it remained floating passively in the water or was making slight movements to keep its head above the water. A video camera (Sony, USA) was placed on top of the water tank to record the test. The water was changed before the introduction of each animal. After the test, the animal was dried with gauze and returned to its cage.
Fluoxetine treatment
Groups of 7-10 infected and 3-5 sex-and age-matched NI control animals were treated with the selective serotonin reuptake The peak of parasitemia occurred at 7-8 dpi. At 18 dpi, no parasites were detected in the peripheral blood and this marked the onset of chronic infection in this model. (B) The graph shows that when mice were subjected to the TST, increased immobility time was observed from 7 and 14 dpi. At 28 and 35 dpi, the immobility times in infected mice were similar to those of NI sex-and age-matched controls. The quantification was over a period of five-minute sessions for the TST. inhibitor (SSRI) fluoxetine (FX) during T. cruzi infection. The animals were treated daily by gavage with 0.1 mL of 10 mg/kg of FX (Prozac, Eli Lilly, Brazil) or injection-grade saline (BioManguinhos, Fiocruz, Brazil) from 14 to 34 dpi. Twenty-four hours after the last dose of FX, the animals were subjected to the TST or FST. Parasitemia and survival rates were evaluated daily. Animals were sacrificed under anesthesia at 35 dpi and the hearts and encephalons were collected.
Benznidazole treatment
Groups of 5-10 Colombian-infected and 5 sex-and agematched NI control animals were treated daily with 100 mg/kg/ day of the trypanocide drug benznidazole (Bz, LAFEPE, Brazil) during acute T. cruzi infection (from 14 to 34 dpi, by gavage). The levels of parasitemia were evaluated as previously described. Twentyfour hours after the last dose of Bz, the mice were subjected to the TST and sacrificed under anesthesia; subsequently, the encephalons were collected. In other experiments, the animals were treated with Bz for 30 days (from 14 to 44 dpi, by gavage) and subjected to the TST at 90 dpi (chronic phase).
Anti-TNF treatment
Chronically T. cruzi-infected (120 dpi) C57BL/6 mice were subcutaneously treated with injection-grade saline (BioManguinhosFiocruz, Brazil) containing 10 lg of the mouse/human chimeric anti-mouse TNF blocking monoclonal antibody infliximab (Remicade), a gift from Schering-Plough of Brazil, at 48-h intervals over 30 days. Infliximab has been previously shown to block in vivo TNF biological activity in murine models (Redlich et al., 2002; Tracey et al., 2008) .
Pentoxifylline treatment
Chronically T. cruzi-infected (120 dpi) C57BL/6 mice were intraperitoneally treated daily with injection-grade saline (BioManguinhos-Fiocruz, Brazil) containing 20 mg/kg pentoxifylline (PTX, Trental, Sanofi, Brazil) for 30 days. PTX is a phosphodiesterase inhibitor that has previously been shown to suppress TNF gene transcription (Doherty et al., 1991) and thereby prevent TNF synthesis and attenuate TNF increases in response to in vivo endotoxins (Zabel et al., 1989) .
Histopathological studies and immunohistochemical staining (IHS)
According to the experimental protocol, groups of 5-7 infected mice and 3 to 5 NI sex-and age-matched control mice were sacrificed under anesthesia at various time points after infection. The encephalons were removed, embedded in tissue-freezing medium (Tissue-Tek, Miles Laboratories, USA) and stored in liquid nitrogen for analysis by IHS. Serial cryostat sections (3-lm thick) were fixed in cold acetone and stained with hematoxylin and eosin (H&E) or subjected to indirect immunoperoxidase or immunofluorescence staining. The H&E-stained sections were examined using light microscopy and scored as previously described (Silva et al., 1999) . For indirect immunoperoxidase staining, parasite antigens were revealed by staining with the polyclonal anti-T. cruzi antibody (produced in our laboratory, LBI/IOC-Fiocruz, Brazil), as previously described (Silva et al., 1999) . For confocal microscopy, parasite antigens were revealed with the same anti-T. cruzi antibody except that the secondary antibody goat anti-rabbit immunoglobulin was labeled with FITC or TRITC (Amersham, England). Astrocytes and microglial cells were revealed with purified anti-glial fibrillary acidic protein (GFAP) antibody (Amersham, England) and purified anti-F4/80 rat antibody (Caltag, USA), respectively. Secondary anti-rat immunoglobulins labeled with FITC or TRITC (Amersham, England) were used to reveal glial cells. For positive controls, heart tissue sections from T. cruzi-infected mice at 30 dpi were used. For cruzi-infected C3H/He mice were treated with vehicle (Saline) or Bz (Bz) from 14 to 44 dpi and subjected to the TST at 90 dpi. The graph indicates the time of immobility in seconds. The findings support a long-lasting beneficial effect of Bz in abrogating T. cruzi-induced depressive-like behavior. Data are expressed as the mean ± SD. Each group consisted of 3 to 10 mice. The figure represents two independent experiments. ⁄ p < 0.05; ⁄⁄ p < 0.01; ⁄⁄⁄ p < 0.001. negative controls, brain tissue sections from infected mice were subjected to all the steps of the reaction excluding the addition of the primary antibodies. The images were analyzed with a confocal microscope (LSM 410, Zeiss, Germany). The presence of T. cruzi antigens in brain tissue sections was also evaluated with a digital morphometric apparatus. The images were analyzed with the AnaliSYS Program and the areas containing parasite molecules were identified as amastigote nests in microscopic fields. Three whole sections were analyzed per brain.
The immunoenzymatic assay for TNF
TNF was assayed with the ELISA sandwich development kit assay from R&D (catalog # 900-k57 lot # 0104054) with rat anti-TNF mAb and a biotin-labeled polyclonal rabbit serum specific for the cytokine. TNF levels were calculated by reference to a standard curve constructed with recombinant cytokine. The sensitivity of this method was 10 pg/mL. The assay was developed using the 2,2 0 -azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) substrate (Sigma, USA) and the reaction was stopped with 20 lL of 20% sulfuric acid solution. The optical density (OD) was read with a microplate reader set to 405 nm.
RT-PCR assay for TNF mRNA
For reverse transcriptase PCR (RT-PCR), mRNA was isolated from the whole encephalon and heart tissue of the C57BL/6 mice by acid guanidinium thiocyanate-phenol-chloroform extraction. The RNA STAT-60 reverse transcriptase-PCR conditions, primer sequences used for the detection of TNF, housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) and PCR product sizes have been published elsewhere (dos Santos et al., 2001) . The PCR products and a molecular weight marker were electrophoresed in 6% polyacrylamide gel and stained with silver nitrate. The densitometry analysis of the gels was conducted on a Densitometer CS-9301PC (Shimadzu, Japan). The PCR data were standardized using mRNA of the housekeeping gene HPRT and fold increases were determined by a comparison with NI controls.
Real-time quantitative RT-PCR for TNF and IDO mRNA
For real-time quantitative RT-PCR (RT-qPCR), total RNA from heart and whole brain samples was extracted using TRI Reagent (Sigma-Aldrich, USA). All reverse transcriptase reactions were performed on 5-lg RNA using a Superscript III kit (cat# 18080-051, Invitrogen, USA) according to the manufacturer's instructions. All RNA samples were reverse transcribed simultaneously to minimize the interassay variation associated with the reverse transcription reaction. Real-time RT-PCR was performed on an ABI Prism 7500 Fast (Applied Biosystems) using Taqman gene expression assays for the cytokine TNF (cat# Mm00443258-m1) and the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) (cat# Mm00492586-m1) purchased from Applied Biosystems (USA). Reactions were performed in duplicate according to the manufacturer's instructions using a 2-lL cDNA template for each reaction in a total volume of 20 lL. The relative quantitative measurement of target gene levels was performed using the DDCt method (Livak and Schmittgen, 2001 ). As endogenous housekeeping control genes, we used the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (cat# Mm99999915-g1) and the b actin (cat# Mm00607939-s1) genes. The RT-qPCR products and a molecular weight marker were electrophoresed in 1% agarose gel and stained with Nancy-520 (Sigma, Switzerland). The RT-qPCR data were standardized using the mRNA of the housekeeping genes GAPDH and b actin and fold increases were determined in comparison with NI controls. In comparison with NI controls, no significant difference in the TNF mRNA expression was detected by semi-quantitative PCR in the whole brain extracts, but increased TNF mRNA was observed in the heart tissue extracts of chronically (120 dpi) infected C57BL/6 mice. Data are expressed as the mean ± SD. Each group consisted of 6 to 8 mice. (C) The experimental design showing that mice were treated with fluoxetine (FX) by gavage with 0.1 mL volume at 10 mg/kg for 20 consecutive days (from 14 to 34 dpi), the hearts were collected and subjected to RT-qPCR for the evaluation of TNF mRNA. Similar TNF mRNA expression was detected by RT-qPCR in the cardiac tissue of saline-and FX-treated infected mice at the end point of the treatment. The results are representative of three independent experiments with two NI controls and three T. cruzi-infected mice per group. (D) The experimental design shows that the infected mice were treated with vehicle (saline), pentoxifylline (PTX; daily) or anti-TNF antibody (infliximab; at 48-h intervals) for 30 days and subjected to the TST at 150 dpi. The graph shows the beneficial effect of PTX and anti-TNF treatment on the time of immobility compared with saline administration in T. cruzi-infected mice. Each symbol represents one mouse. Data are expressed as the mean ± SD. Each group consisted of 3 to 6 mice. The figure represents two independent experiments. ⁄ p < 0.05; ⁄⁄ p < 0.01.
Statistical analyses
The data are expressed as the arithmetic mean ± SD. To compare the two groups (NI and T. cruzi) in the acute and chronic phases, Student's t test was adopted to analyze the statistical significance of the apparent differences (Figs. S1, S2, S3C-S3F, 2, 3 and 7A-7B). The Shapiro-Wilk and Levene tests were used to analyze the normality (p < 0.05) and homogeneity of variances (p < 0.05), respectively. Kruskal-Wallis tests with Dunn's Multiple Comparison tests were used to determine whether one parameter varied among three or more different groups (Figs. 4B, 5A , 5B, 5C, 5E, 6A, 6C and 7D). A one-way ANOVA with the Bonferroni test was used to compare the treated and non-treated NI and T. cruzi groups (Fig. 5D and F) . Differences were considered statistically significant at p < 0.05. All statistical tests were performed using GraphPad Prism 5.0 (GraphPad software, USA).
Results
The infiltration of the CNS by inflammatory cells during T. cruzi infection depends on the genetic background of the host
When acutely infected with the type I Colombian T. cruzi strain, the C3H/He, but not the C57BL/6, mice showed elevated parasitemia. In mice of both lineages, the peak of parasitemia was observed between 42 and 45 dpi and decreased thereafter; during the chronic phase of infection, parasites were rarely found in circulating blood (Fig. 1A) . Approximately 80% of the animals survived and developed chronic infection (Fig. 1B) . In a previous work, we showed that C3H/He mice are susceptible to acute phase-restricted meningoencephalitis, whereas C57BL/6 mice are resistant to T. cruzi-induced CNS inflammation (Roffê et al., 2003) . In mice of both lineages during the acute phase, CNS parasitism was mainly detected as amastigote forms of the T. cruzi parasite inside GFAP + cells (astrocytes) and F4/80 + cells (microglial cells) spread throughout the brain parenchyma (Fig. 1C) . Rarely, parasite-positive areas were seen during the chronic phase (data not shown). Histopathological analyses revealed that in T. cruzi-infected C3H/He mice, brain inflammation was restricted to the acute phase of infection, when inflammatory cells were seen in the parenchyma and perivascular cuffs with one or more layers of infiltrating cells (Fig. 1D ). In the acutely infected C3H/He mice, several CNS areas were affected including hippocampus (Fig. 1D) , a brain region involved in depression in mouse models (Bahi and Dreyer, in press ). In contrast, no inflammatory infiltrates were detected in the brain of acutely and chronically T. cruzi-infected C57BL/6 mice ( Fig. 1D) , resembling the CNS of NI controls. These data are summarized in Table S1 . Therefore, these models allowed us to test whether behavioral alterations were induced during chronic T. cruzi infection and whether they were a long-term consequence of acute CNS inflammation.
Locomotor/exploratory alterations are absent in the T. cruziinduced CNS inflammation-susceptible C3H/He mice but present in the resistant C57BL/6 mice
To test whether behavioral alterations are present in T. cruzi infection, we initially subjected infected mice to the open-field test and analyzed the numbers of peripheral and central crossed lines and rearing episodes. Acutely infected C57BL/6 mice exhibited a significant (p < 0.001; t (11) > 5.124) decrease in locomotor/exploratory activity compared with the NI controls in five-, ten-and thirty-minute sessions (Fig. S1A) . Chronically T. cruzi-infected C57BL/6 mice also presented a significant decrease in locomotor/ exploratory activity expressed as the reductions in the number of crossed peripheral (p < 0.0001; t (9) = 11.89) and central (p < 0.01; t (9) = 4.107) lines and rearing episodes (p < 0.0001; t (9) = 8.888) in five-minute sessions (Fig. S1B ). This finding confirms our previous data (Silva et al., 2010) . Conversely, when T. cruzi-infected C3H/He mice were compared with sex-and age-matched NI controls, there were no significant differences (p > 0.05; t (6) < 1.500) in the numbers of crossed peripheral and central lines or rearing episodes during the acute (30 dpi; Fig. 2A ) or chronic (90 dpi; Fig. 2B ) phases of infection in five-minute sessions of the open-field test. Furthermore, no significant (p > 0.05; t (11) < 1.000) behavioral alterations were detected in acutely (Fig. S2A) or chronically (Fig. S2B) T. cruzi-infected C3H/He mice when their performances in ten-and thirtyminute sessions of the open-field test were analyzed. Considering that sickness features may contribute to behavioral alterations such as decreases in spontaneous locomotor/exploratory activity (Rogers et al., 2001) , we further assessed sickness behavior by checking body weight loss (which reveals loss of appetite), apathy and increase in temperature (indicative of fever). During the recorded interval (from 7 to 150 dpi), apathy, characterized as prostration, was not detected in C3H/He and C57BL/6 mice infected with a low-level inoculum of the Colombian T. cruzi strain. The kinetic study (from 7 to 90 dpi) of body weight revealed no significant (p > 0.05; t (14) < 2.000) body weight loss in Colombian-infected C3H/He (Fig. S3A ) and C57BL/6 (Fig. S3B) mice. These data were confirmed in temporally specific experiments during the acute ( Fig. S3C ; p > 0.05; t (13) = 1.731) and chronic ( Fig. S3E ; p > 0.05; t (12) = 1.489) phases of infection of C3H/He mice and the chronic infection of C57BL/6 mice ( Fig. S3G ; p > 0.05; t (13) = 1.685). During acute infection (30 dpi), C3H/He mice exhibited no alterations in rectal temperature ( Fig. S3D ; p > 0.05; t (13) = 1.250), although a significant decrease in temperature was observed during the chronic phase of infection ( Fig. S3F ; p < 0.001; t (12) = 4.535) in comparison with sex-and age-matched controls. No significant (p > 0.05; t (13) = 1.462) alteration in rectal temperature was detected in chronically T. cruzi-infected C57BL/6 mice. Altogether, these data demonstrate that C3H/ He and C57BL/6 mice infected with a low inoculum of the Colombian strain do not exhibit signs of sickness behavior. Furthermore, T. cruzi-infected C3H/He mice do not show locomotor/exploratory activity alterations during the acute or chronic phases of infection.
Depressive-like behavior is present during experimental T. cruzi infection
We used the FST and TST to assess depressive-like behavior, as recently described in mouse models of chronic stress and immune challenge with LPS (Painsipp et al., 2011 ). In our model, acutely (30 dpi) the Colombian-infected C3H/He mice showed a significant increase in immobility time in the FST compared with NI controls (Fig. 3A ; p < 0.001; t (16) = 4.092). Similar results were obtained when another group of infected mice was analyzed during the chronic infection phase (90 dpi) compared with sex-and age-matched NI controls ( Fig. 3A ; p < 0.001; t (15) = 5.374). Corroborating these data, Colombian-infected C3H/ He mice showed elevated immobility during the acute (p < 0.001; t (16) = 5.070) and chronic (p < 0.001; t (14) = 7.355) infection phases compared with NI mice in the TST (Fig. 3B) . Therefore, in the absence of active CNS inflammation, chronically T. cruzi-infected C3H/He mice presented depressive-like behavior that may have been a result of acute CNS inflammation.
Depressive status is independent of acute T. cruzi-induced CNS inflammation
Our initial hypothesis was that behavioral alterations detected during chronic T. cruzi infection were long-term consequences of acute CNS inflammation. However, this was not found to be correct. In C57BL/6 mice, which are resistant to Colombian-induced acute CNS inflammation (Fig. 1D) , we observed a significantly increased immobility time in the TST during the acute (30 dpi; p < 0.05; t (14) = 2.479) and chronic (90 dpi; p < 0.001; t (13) = 8.945) phases of infection compared with sex-and agematched NI controls (Fig. 3C) . Our findings suggest that T. cruzi-induced depressive-like behavior is present in the acute and chronic infection phases independent of acute CNS inflammation. Hence, depressive status is not a long-term consequence of the T. cruzi-induced acute brain inflammation.
3.5. The type I, but not type II, T. cruzi strain induces chronic depressive-like behavior Considering the genotypic and biological diversity of T. cruzi strains (Zingales et al., 2012) , we wondered whether the depressive profile induced by infection with the type I Colombian strain could also be elicited by the distinct type II Y strain. To investigate this question, C3H/He mice were infected with 500-bt of the Y strain and followed daily for parasitemia and mortality. Parasitemia was detected as early as 4 dpi, peaked at 7-8 dpi and was controlled subsequently. No circulating parasite was detected at or after 18 dpi, which marked the resolution of acute infection and the onset of chronic infection (Fig. 4A ). All the infected animals survived (data not shown). Next, we investigated whether the mice appeared to be depressed with the TST. A significant increase in immobility was detected at 7 dpi (p < 0.05; at the peak of parasitemia) and reached a maximum at 14 dpi (p < 0.001). At 28 and 35 dpi, the immobility of infected mice was similar (p > 0.05) to that of sex-and age-matched NI controls (Fig. 4B) . Importantly, the duration of immobility time did not correlate with CNS parasitism: at 7 dpi in the Y strain, when behavioral alterations were first detected, no parasites were found by IHS in brain sections. A few parasites were detected in the CNS tissue at 14 dpi. CNS parasitism peaked at 28 dpi and declined at 35 dpi ( Fig. 4C and D) . CNS parasitism was found mainly in the cerebellum (data not shown) and hippocampus ( Fig. 4D) at 35 dpi when depressive-like behavior was not detected in the Y-strain-infected C3H/He mice (Fig. 4B) . Thus, there was no association between CNS parasitism and depressive-like behavior. Furthermore, the type I Colombian T. cruzi strain, but not the type II Y strain, induced chronic depressivelike behavior in mice.
3.6. T. cruzi-induced depressive-like behavior is associated with increased IDO mRNA expression in the CNS and abrogated by treatment with a selective serotonin reuptake inhibitor Depressive-like behavior was detected in the Colombian-infected C3H/He mice at 30 dpi and persisted until 90 dpi (Fig. 3A  and B) . Although a consistent, slight increase in immobility time was detected at 14 dpi, the onset of depressive-like behavior in the Colombian-infected C3H/He mice occurred at 21 dpi, when a significant increase in immobility was detected, and persisted during the chronic phase ( Fig. 5A ; p < 0.05; H (5) = 29.46). Given the participation of tryptophan-degrading enzymes such as IDO in depression , we investigated the status of IDO mRNA in the CNS of T. cruzi-infected mice. Compared with NI controls, an increase in IDO mRNA expression was observed in the CNS of T. cruzi-infected mice during the acute (30 dpi) and chronic (90 dpi) phases of infection (Fig. 5B) . To further investigate depressive-like behavior during T. cruzi infection, Colombian-infected C3H/He and C57BL/6 mice were subjected to treatment with the selective serotonin reuptake inhibitor (SSRI) antidepressant fluoxetine (FX) from 14 to 34 dpi and analyzed at 35 dpi (Fig. 5C ). As expected (D'Souza et al., 2004) , FX-treated mice presented body weight loss (p < 0.001; H (3) = 19.87) when compared with saline-treated infected mice (Fig. 5C ). Infected mice treated with FX exhibited significantly decreased immobility times in the FST when compared with not treated (Nt; p < 0.001; t (2) = 12.19) or saline-treated (Saline; p < 0.01; t (2) = 10.30) T. cruzi-infected C3H/He mice (Fig. 5D) . These results were corroborated by the TST (Fig. 5E ; p < 0.001; H (2) = 15.68), supporting that FX abrogated T. cruzi-induced depressive-like behavior. Similarly, FX administration reduced immobility times in the TST for T. cruzi-infected C57BL/6 mice compared with Nt (p < 0.001; t (2) = 11.16) or saline-treated (p < 0.001; t (2) = 10.90) T. cruzi-infected mice (Fig. 5F) . Therefore, T. cruzi infection induced depressive-like behavior that was independent of CNS inflammation but paralleled the increased IDO mRNA expression in the CNS and was responsive to the administration of the SSRI antidepressant FX.
Depressive-like behavior is alleviated by benznidazole treatment
Because our hypothesis that the depressive-like behavior present in chronically T. cruzi-infected mice is a long-term consequence of acute CNS inflammation was incorrect, we explored the contribution of the parasite to depressive statuses observed during experimental infection. C3H/He mice were infected with the Colombian strain and treated with Bz, a parasiticide drug (Cançado, 2002) . Mice were treated with Bz alone or with Bz and FX, to search for a possible reciprocal interference of the drugs, and subjected to the TST. After 20 days of treatment (from 14 to 34 dpi), no circulating parasites were observed in the Bz-treated mice and high numbers of circulating parasites were observed in the non-treated and saline-and FX-treated mice (Table 1) . Furthermore, when combined with Bz, FX administration did not alter the efficacy of Bz (Table 1) . Importantly, Bz treatment significantly (p < 0.05) decreased the immobility time of T. cruzi-infected mice in the TST compared with saline-treated infected mice (Fig. 6A) . Furthermore, the combined treatment with Bz and FX also significantly abrogated the depressive-like behavior induced by T. cruzi infection (Fig. 6A ) in a manner similar to that of FX alone (p < 0.001; H (4) = 33.97); this finding supports the idea that Bz does not interfere with the actions of FX. Analysis of the CNS by IHS revealed an absence of parasite antigens in the Bz-treated and Bz + FX-treated mice (Fig. 6B) ; this finding further reinforces the idea that FX does not interfere with the efficacy of Bz. Conversely, the numbers of parasite-antigen-positive areas detected in the CNS were similar in saline-and FX-treated infected mice (Fig. 6B) , supporting the idea that FX neither ameliorates nor aggravates CNS parasitism. Furthermore, comparable intensities of inflammatory cell infiltrates were found in the CNS of mice from all analyzed groups (Fig. 6B) . Moreover, when mice treated with Bz during the acute phase of T. cruzi infection (from 14 to 44 dpi) were subjected to the TST during chronic infection (at 90 dpi), the beneficial effect of Bz on depressive-like behavior was still apparent ( Fig. 6C ; p < 0.01; H (3) = 13.94). Collectively, these data show that the increased immobility times observed in T. cruzi-infected mice are reduced by treatment the decreases parasite load, which supports the direct or indirect participation of T. cruzi in triggering chronic depressive-like behavior.
TNF-modulating drugs abolish depressive-like behavior
IFNc-and TNF-induced IDO activation is associated with depressive behavior . The administration of TNF to mice induces acute depressive-like behavior (Kaster et al., 2012) . Furthermore, consistent increases in TNF expression have been associated with the severity of chronic Chagas disease (Lannes-Vieira et al., 2011) . Therefore, we investigated the participation of TNF in depressive-like behavior during chronic T. cruzi infection. Concomitant with the depressive-like behavior revealed by increased immobility times in the TST (data not shown), chronically T. cruzi-infected (120 dpi) mice exhibited elevated serum TNF levels compared with sex-and age-matched NI controls (Fig. 7A) . Infection by T. cruzi did not alter TNF mRNA expression in tissue from the whole (Fig. 7B) ; however, TNF mRNA expression was upregulated in the cardiac tissue at 120 dpi (Fig. 7B) . Given that FX decreased the T. cruzi-induced increase in immobility time (Figs. 5 and 6 ) and the previous demonstration that FX exhibits anti-inflammatory activity (Abdel-Salam et al., 2004; Koh et al., 2011) , we tested whether the beneficial effect of the SSRI FX was associated with the systemic down-regulation of TNF mRNA. As shown in Fig. 7C , FX administration had no effect on TNF mRNA expression, which was detected at similar levels in the cardiac tissue of saline-and FX-treated infected C57BL/6 mice. Therefore, the beneficial action of the SSRI FX was independent of interference in TNF status. Lastly, we tested whether TNF modulators inhibit T. cruzi-induced depressive-like behavior. When chronically T. cruziinfected C57BL/6 mice were treated for 30 days (from 120 to 149 dpi) with the immunomodulator pentoxifylline (PTX, daily) or the chimeric anti-TNF neutralizing monoclonal antibody infliximab (anti-TNF, at 48-h intervals) and analyzed at 150 dpi (Fig. 7D) , no parasite burden was observed (data not shown). Notably, PTX and anti-TNF therapies have a beneficial effect that significantly reduces TST immobility times compared with vehicletreated T. cruzi-infected mice ( Fig. 7D ; p < 0.05; H (2) = 14.09). Thus, parasite-triggered systemic TNF upregulation contributes to the depressive-like behavior in chronic T. cruzi infection.
Discussion
The present study was conducted to test the contribution of T. cruzi-induced CNS inflammation and the parasite strain infecting the host to chronic behavioral alterations. Mice of the C3H/He lineage infected with the type I Colombian T. cruzi strain, a model of self-resolving acute phase-restricted brain inflammation, present depressive-like behavior during the chronic phase of infection, supporting the idea that depressive status is independent of active CNS inflammation. Using infected C57BL/6 mice, which are refractory to acute brain inflammation, we confirmed that behavioral alterations were independent of the acute brain inflammation and, therefore, not a long-term consequence of this inflammatory process. However, the induction of chronic depressive-like behavior was dependent on the T. cruzi strain infecting the host. Furthermore, T. cruzi-induced depressive-like behavior was paralleled by increased IDO mRNA expression in the CNS and abrogated by the SSRI antidepressant drug FX. Moreover, this behavioral alteration was inhibited by the trypanocide drug Bz, confirming that the parasite plays a direct or indirect protagonistic role in the induction of depressive-like behavior. Finally, we provided evidence that TNF plays a pivotal role as an immunological stressor in depressive-like behavior during chronic T. cruzi infection.
The effects on the CNS during the acute phase of T. cruzi infection have been related to neurocognitive and/or cerebellar syndromes during chronic infection (Spina-Franca, 1998; Pittella, 2009) . Therefore, we hypothesized that the behavioral abnormalities described in chronic Chagas disease (Prost et al., 2000; Mosovich et al., 2008; Silva et al., 2010) are long-term consequences of acute CNS inflammation. To investigate this hypothesis, we infected C3H/He and C57BL/6 mice with a low inoculum of the type I Colombian T. cruzi strain that, without trypanocide therapy, results in acute phase survival ($80%) and the establishment of chronic infection. Most importantly, the T. cruzi-infected C3H/He mice exhibited acute phase-restricted self-resolving CNS inflammation, whereas the infected C57BL/6 mice were refractory to brain inflammation, consistent with previous data (Silva et al., 1999; Roffê et al., 2003) . Therefore, these models were suitable to investigate our original proposal. We tested whether T. cruzi infection led to behavior alterations in infected mice using the open-field test to assess locomotor/anxiety abnormalities (Hall, 1941) and the FST and TST to evaluate depressive-like behavior (Porsolt, 2000; Steru et al., 1985; Ma et al., 2011; Painsipp et al., 2011) . T. cruzi-infected C57BL/6 mice had abnormalities compatible with locomotor/exploratory alterations and anxiety in the open-field test in the acute and chronic phases, as previously described (Silva et al., 2010) . Conversely, using the open-field test, neither locomotor abnormalities nor anxiety were detected in acute or chronically T. cruzi-infected C3H/He mice. This finding corroborated previous data showing that, regardless of the level of CNS parasitism and inflammation, T. cruzi-infected animals have no locomotor alterations in the acute infection phase (Caradonna and Pereiraperrin, 2009) . Our current data extend this concept and suggest that the persistence of the parasite in the CNS during the chronic phase does not cause locomotor/exploratory abnormalities during T. cruzi infection. Interestingly, recent data support the idea that the CNS inflammation induced by acute stress is neuroprotective, at least for anxiety (Lewitus et al., 2008) . In our experiments, C57BL/6 mice were refractory to T. cruzi-induced CNS inflammation, whereas C3H/He mice presented acute phaserestricted meningoencephalitis with enrichment in CD8 + T-cells and macrophages (Silva et al., 1999; Roffê et al., 2003) . Accordingly, the selective trafficking of inflammatory cells to the CNS may explain the differential responses of the resistant C3H/He mice and susceptible C57BL/6 mice to T. cruzi-induced locomotor/exploratory alteration that may indicate anxiety; however, further studies are needed to determine the mechanism of this difference. Studies conducted in patients with chronic Chagas disease have revealed the presence of cephalea, confusion and depression (Jorg and Rovira, 1981; Mangone et al., 1994; Marchi et al., 1998) . These data led us to investigate T. cruzi-induced depressive-like behavior in C3H/He and C57BL/6 mouse models that reproduce important pathological aspects of Chagas disease (Medeiros et al., 2009; Silva et al., 2010; Silverio et al., 2012) . Notably, our experiments showed that, when infected with a low inoculum of the type I Colombian strain, neither mouse lineage presented sickness-related behavior. Moreover, our results show that T. cruzi-infected C3H/He mice, which are susceptible to acute phase-restricted CNS inflammation, exhibit depressive-like behavior during the acute and chronic phases of infection. Therefore, this behavioral alteration was independent of active CNS inflammation, supporting the hypothesis that the chronic depressive-like behavior could be a long-term consequence of acute brain inflammation. However, T. cruzi-infected C57BL/6 mice, which are refractory to CNS inflammation, also displayed depressive-like behavior during the acute and chronic phases of infection. Thus, our findings suggest that T. cruzi-induced depression is independent of the active and previous trafficking of inflammatory cells to the CNS. Therefore, other biological mechanisms must explain the genesis of the chronic depression associated with T. cruzi infection.
Given the genotypic and biological heterogeneity of T. cruzi strains (Zingales et al., 2012) , we attempted to clarify whether chronic depressive status was associated with the parasite strain infecting the host. Toward this end, we tested type I Colombian and type II Y T. cruzi strains, parasite prototypes that represent the strains most frequently found in nature (Zingales et al., 2012) . Infection with the type I Colombian strain led to acute (21, 30 dpi) and chronic (90, 120 and 150 dpi) depressive-like behavior in C3H/He mice. However, the enhanced immobility time due to infection with the type II Y T. cruzi strain was restricted to the acute infection (7 and 14 dpi), which may be linked to the weight loss and temperature alteration indicators of sickness behavior (da ), but did not cause chronic depres-sive-like behavior in C3H/He mice, despite parasites and inflammation being detected in the CNS until late infection (35 dpi). Thus, these data show that in situ inflammation is not a crucial determinant of T. cruzi-induced depressive-like behavior. Moreover, the kinetics of the colonization of the CNS by the parasite suggests that the presence of T. cruzi in the CNS is not a crucial cause of depression; CNS parasitism persisted at 35 dpi, when immobility time in the TST was similar to NI controls. However, when acutely Colombian-infected animals were treated with the parasiticide drug Bz, parasitemia (indicative of systemic parasitism) and CNS parasitism were controlled, as expected (Silva et al., 2010) . In parallel, decreased immobility times were observed in the TST and FST. Together, these results indicate direct or indirect systemic roles for the parasite and/or parasite-induced factors in the induction of depressive-like behavior. Interestingly, T. cruzi trans-sialidase (also known as parasite-derived neurotrophic factor -PDNF) activates the neurotrophic receptor TrkC, promoting the survival of neuronal and glial cells; this raises the possibility that the recognition of TrkC underlies the regenerative events in the nervous tissues of patients with Chagas disease (Weinkauf and Pereiraperrin, 2009 ). Thus, our data showing Y-strain parasite persistence in the CNS at 35 dpi in the absence of depressive-like behavior may support a neuroprotective role of parasite persistence in the CNS. In the chronically Colombian-infected C57BL/6 and C3H/He mice, depressive-like behavior was present in the absence and presence of rare parasites in the CNS. Therefore, further studies are warranted to elucidate the mechanisms governing the relationship between T. cruzi and the host that might protect or contribute to chronic behavioral abnormalities. Other intracellular parasites that afflict the brain, such as Plasmodium and Toxoplasma, also cause cognitive disturbances (Idro et al., 2007; Zhu, 2009) . It is possible that, in apparently silent brain forms, these parasites can modify synaptic circuits. Interestingly, in rodents, chronic Toxoplasma infection is associated with behavioral alterations that enhance the risk of feline predation, a putative selective advantage to the parasite (Holliman, 1997; Silva and Langoni, 2009 ). Perhaps depressive-like behavior in hosts such as rodents, other sylvatic animals and humans may also confer a selective advantage for T. cruzi.
The knowledge of being a Chagas disease carrier can elicit psychological disturbances, particularly because there is no cure for this disease (Petana, 1980; Mota et al., 2006) . The demonstration that treatment with Bz during the acute experimental infection had a beneficial effect and abolished depressive-like behavior in the chronic phase of infection places the parasite as the central trigger of the behavioral alterations and reinforces the requirement for prompt diagnosis and etiological treatment of infected patients Rassi et al., 2010) .
Chagas disease is considered a suitable model for studying the association between depression and heart disease in the presence of chronic inflammation (Mosovich et al., 2008) . In fact, our experimental models are appropriate for studying such an association because Colombian T. cruzi-infected mice of the C3H/He and C57BL/6 lineages that present chronic depressive behavior reproduce aspects of human Chagas disease (Dutra et al., 2009; Rassi et al., 2010) such as chronic heart inflammation and systemic immune dysbalance favoring IFNc and TNF (Medeiros et al., 2009 ). The pro-inflammatory cytokines IFNc and TNF enhance tryptophan degradation by IDO; this effect has important neuropsychiatric implications because tryptophan catabolites (TRYCATs) may induce neurodegeneration and tryptophan is a precursor of serotonin Maes et al., 2009) . A previous study demonstrated that tryptophan degradation and IDO expression are increased in the spleen and muscles in acutely T. cruzi-infected mice and associated IDO with resistance to infection (Knubel et al., 2010) . Thus, given that IDO fluctuation in the CNS may affect serotonin and contribute to depression , we assessed IDO mRNA expression in the CNS of T. cruzi-infected mice. Our data showed remarkable increases in IDO mRNA expression in the CNS of acutely and chronically T. cruzi-infected mice; therefore, locally enhanced IDO may contribute to serotonin paucity and the depressive-like behavior observed in these mice. Moreover, infected mice of both lineages are responsive to FX, an SSRI antidepressant (Vaswani et al., 2003) . Therefore, depressive-like behavior may be caused by direct or indirect effects of T. cruzi-triggered TRYCATs or alterations in serotonin synthesis.
Pathogen-borne products and host immune response mediators such as glucocorticoids and cytokines may contribute to depression Maes et al., 2009; Gibb et al., 2011) . TNF, which affects T cells and increases glucocorticoid levels and apoptosis, may play a role in depression (Miller, 2010; Rook et al., 2011) . Apparently, in T. cruzi infection, the local acute CNS inflammation does not influence the depressive profile. Therefore, based on the effect of T. cruzi infection on immune system activation (Junqueira et al., 2010) , we hypothesized that pro-inflammatory cytokines may contribute to T. cruzi-induced depressive-like behavior. Systemic immune abnormalities are commonly found in the chronic phase of T. cruzi infection in both C3H/He and C57BL/6 mice (Medeiros et al., 2009; Silverio et al., 2012) . In chronically Colombian-infected C57BL/6 mice, behavioral alterations were paralleled by increases in TNF expression in the serum and cardiac tissue but not in the CNS, suggesting a possible role for systemically produced TNF in T. cruzi-induced depression.
The SSRI antidepressant FX has anti-inflammatory activity; it decreases IFNc, upregulates IL-10 and inhibits the activation of NF-jB (Abdel-Salam et al., 2004; Koh et al., 2011) . NF-jB is a nuclear factor crucial for TNF gene transcription (Tracey et al., 2008 ). Hence, we tested whether the beneficial effect of FX in T. cruzi-induced depressive disorder was related to the systemic down-regulation of TNF mRNA. This was not the case, however, as similar TNF mRNA levels were detected in saline-and FXtreated T. cruzi-infected mice. Subsequently, the participation of TNF in T. cruzi-induced depressive-like behavior was tested by treating chronically (120 dpi) T. cruzi-infected C57BL/6 mice with PTX, a phosphodiesterase inhibitor that decreases TNF synthesis (Shaw et al., 2009) , or the chimeric anti-TNF neutralizing monoclonal antibody infliximab (Tracey et al., 2008) . Although TNF plays an important role in parasite control in the acute phase of infection (Lannes-Vieira et al., 2011) , no parasite burden was observed, suggesting that infection was not reactivated or reacutized by interfering with TNF in chronically T. cruzi-infected mice. Importantly, the immobility time assessed by the TST was significantly decreased after PTX and anti-TNF administration, supporting the idea that TNF may have a pivotal role in the induction of depressive-like behavior during chronic infection. Accordingly, exogenous TNF administration induces acute depressive-like behavior, supporting a role for this cytokine in behavioral alterations (Kaster et al., 2012) . Despite the very low parasite load, patients develop more severe forms of Chagas disease during the chronic stage (Dutra et al., 2009; Rassi et al., 2010) , when high TNF levels in the serum are detected (Ferreira et al., 2003; Talvani et al., 2004; Gomes et al., 2005) . Our study highlights that T. cruzi-induced long-lasting TNF expression may contribute to depressive-like behavior in Chagas disease. Because non-infectious chronic cardiac disorders are associated with high TNF levels (Shaw et al., 2009) , our findings become more broadly important. Interestingly, Bz and PTX also regulate NF-jB activation (Shaw et al., 2009; Manarin et al., 2010) . Therefore, the genesis of depressive-like behavior in Chagas disease may reside in a complex network of interactions triggered by the parasite that involve the immune stressor TNF and mechanisms that may induce increase in TRYCATs and serotonin paucity (Fig. S4) . Altogether, our findings support the existence of a chronic nervous form of Chagas disease, contribute to the understanding of pathogen-borne cytokine-driven chronic depression and open new avenues for therapeutic interventions in depressive disorders.
Conclusion and limitations
Our results indicate that T. cruzi infection provokes a cytokinedriven depressive-like behavior in experimental models independent of active or prior acute CNS inflammation. In our studies, the TST and FST used to assess depressive-like behavior are based on immobility, restringing the strength of our findings. The use tests based on other behavioral paradigm as food consumption including the sucrose preference test, was hampered in this model of parasitic infection as sugar consumption may fuel parasite growth. In T. cruzi-infected mice impaired pancreas morphology and glucose metabolism was associated with increased glycemia (Novaes et al., 2012) , a condition which increased parasitemia and mortality (Tanowitz et al., 1988) . Importantly, trypanocide therapy administered during the acute infection promptly abrogated chronic depression; this finding supports a direct or indirect contribution of the parasite and parasite-triggered factors in depression. Furthermore, T. cruzi-induced IDO upregulation and the beneficial effect of the SSRI FX in reducing immobility time may implicate serotonin paucity in this process. Moreover, T. cruzi infection systemically upregulates TNF and the TNF modulators PTX and anti-TNF have beneficial effects on chronic depression, reinforcing the inflammatory component of depressive disorders. Thus, our data open a new avenue for exploration regarding the parasite factors and molecular mechanisms governing behavioral alterations in Chagas disease. More broadly, our findings disclose PTX as a therapeutic tool that should be further explored in chronic depressive disorders.
Additional studies are required to clarify whether functional and structural brain pathology play roles in the development of mood disorders in Chagas disease. Parasite/host interactions are highly complex and may diverge in specific sites inside the host. In the present work, these complex interactions are exemplified by the detection of increased TNF expression systemically and in heart tissue but not in the whole brain of T. cruzi-infected mice. Further experiments are required to clarify whether TNF is expressed at low levels in distinct CNS regions during T. cruzi infection. Additionally, the fact that FX did not modulate systemically produced TNF precludes ruling out the possibility that this may occur in discrete CNS areas. Additionally, the beneficial effect of the SSRI FX on T. cruzi-induced depression may reside in an alternative cytokine circuit not explored in our study. Lastly, in the present work, we did not explore the mechanisms of the beneficial effect of TNF blockers in chronic depression. Further efforts to decipher whether TNF blockers interfere with cytokine-driven tryptophan deprivation or with a currently unknown pathway are warranted.
